View Full Paper

Owner Consent Verified
Report 4.2

AIOps Adoption in Pharmaceutical Firms: Ethical Considerations — Post-Pandemic Lessons

38
Pages
Chicago
Style
~ 40–56 mins
Reading Time
MLOps AI Cybersecurity
Abstract

This report investigates “AIOps Adoption in Pharmaceutical Firms: Ethical Considerations — Post-Pandemic Lessons” using a survey-based structural equation modeling. Through a economic lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.

Download PDF Order Similar Paper Save

AIOps Adoption in Pharmaceutical Firms: Ethical Considerations — Post-Pandemic Lessons

ABSTRACT
AIOps Adoption in Pharmaceutical Firms: Ethical Considerations — Post-Pandemic Lessons is unpacked across themes: KPIs, equity, change enablement, and security. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
19 Pages 4.9
Robotic Process Automation and Resilience And Continuity among EU Startups — Post-Pandemic Lessons
Psychology AIOps Impact
View Paper
40 Pages 4.3
Platform Engineering and Market Entry Strategy among EU Startups — 2021–2029 Trends
Telemedicine Cold Chain RPA
View Paper
17 Pages 4.6
Quantum Computing Adoption in Remote Software Engineers: Scaling And Replication — Post-Pandemic Lessons
InsurTech Psychology Blockchain
View Paper